TheStockAdvisors.com Daily Digest Today's top picks from the nation's leading newsletter advisors |
by Paul Goodwin, editor Cabot China & Emerging Markets Report There's a little paradox in the identity of Seaspan, a company that specializes in container ships, which it acquires, crews, maintains and sails over the Seven Seas.The paradox is that, despite all that ship-owning and sailing, Seaspan isn't actually a shipping company -- rather, it's a ship leasing company. Read more... |
by Nicholas Vardy, editor Global Bull Market Alert Novo Nordisk A/S is a Danish pharmaceutical company that focuses on diabetes care and biopharmaceuticals.Novo Nordisk is a quiet giant, employing 30,000 people in 76 countries; we think investors could double their money with this profit machine. Read more... |
by Jim Trippon, editor ETF Profit Report Hunting for value these days is a tough task as this market rally has elevated so many stocks and ETFs to new 52-weeks with almost no buyable dips.Market Vectors Coal ETF -- a new addition to our model ETF portfolio -- is one example of finding some value. Read more... |
|
|
by Andy Obermueller, editor Fast-Track Millionaire Accretive Health has been a solid performer in the Fast-Track Portfolio, jumping from $13 to nearly $20 in six months.I admit, the company is not very sexy -- helping hospitals maximize their revenue cycle. But I what I've been looking at with the company is very alluring indeed. Read more... |
by Mike Cintolo, editor Cabot Top Ten Weekly OpenTable is still small, with $99 million in annual revenues.But it's revolutionized the business of making restaurant reservations in the U.S. and now it's expanding internationally into Canada, Germany, Japan, Mexico and the United Kingdom. Read more... |
There's a little paradox in the identity of Seaspan, a company that specializes in container ships, which it acquires, crews, maintains and sails over the Seven Seas.
Novo Nordisk A/S is a Danish pharmaceutical company that focuses on diabetes care and biopharmaceuticals.
Hunting for value these days is a tough task as this market rally has elevated so many stocks and ETFs to new 52-weeks with almost no buyable dips.
Accretive Health has been a solid performer in the Fast-Track Portfolio, jumping from $13 to nearly $20 in six months.
OpenTable is still small, with $99 million in annual revenues.
Nessun commento:
Posta un commento